BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 24654740)

  • 1. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients.
    D'Amico G; Pasta L; Morabito A; D'Amico M; Caltagirone M; Malizia G; Tinè F; Giannuoli G; Traina M; Vizzini G; Politi F; Luca A; Virdone R; Licata A; Pagliaro L
    Aliment Pharmacol Ther; 2014 May; 39(10):1180-93. PubMed ID: 24654740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
    D'Amico G; Morabito A; D'Amico M; Pasta L; Malizia G; Rebora P; Valsecchi MG
    Hepatol Int; 2018 Feb; 12(Suppl 1):34-43. PubMed ID: 28681347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
    Liu TL; Trogdon J; Weinberger M; Fried B; Barritt AS
    Dig Dis Sci; 2016 Nov; 61(11):3335-3345. PubMed ID: 27480088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient ≥20 mm Hg.
    Jindal A; Bhardwaj A; Kumar G; Sarin SK
    Am J Gastroenterol; 2020 Oct; 115(10):1624-1633. PubMed ID: 32453061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis.
    Navadurong H; Thanapirom K; Wejnaruemarn S; Prasoppokakorn T; Chaiteerakij R; Komolmit P; Treeprasertsuk S
    World J Gastroenterol; 2023 Aug; 29(32):4873-4882. PubMed ID: 37701131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis.
    Wiegand J; Kühne M; Pradat P; Mössner J; Trepo C; Tillmann HL
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1443-50. PubMed ID: 22530565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy.
    Bruno S; Saibeni S; Bagnardi V; Vandelli C; De Luca M; Felder M; Fracanzani AL; Prisco C; Vitaliani G; Simone L; Gaeta GB; Stanzione M; Persico M; Furlan C; Stroffolini T; Salerno F; Maisonneuve P; Almasio PL;
    Am J Gastroenterol; 2013 Jul; 108(7):1112-22. PubMed ID: 23732467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of hepatocellular carcinoma and cirrhosis-associated complications in patients with rheumatoid arthritis: a 10-year population-based cohort study in Taiwan.
    Hsu CS; Lang HC; Huang KY; Chao YC; Chen CL
    Hepatol Int; 2018 Nov; 12(6):531-543. PubMed ID: 30426396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with liver cirrhosis show worse survival if decompensation occurs later during course of disease than at diagnosis.
    Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
    Scand J Gastroenterol; 2018 Apr; 53(4):475-481. PubMed ID: 29513096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study.
    Bruno S; Crosignani A; Facciotto C; Rossi S; Roffi L; Redaelli A; de Franchis R; Almasio PL; Maisonneuve P
    Hepatology; 2010 Jun; 51(6):2069-76. PubMed ID: 20196120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status and perspectives of diagnosis and treatment of complications related to liver cirrhosis].
    Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):241-245. PubMed ID: 28494539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical course of decompensated alcoholic cirrhosis: a prospective study of 165 patients.
    Alvarez MA; Cirera I; Solà R; Bargalló A; Morillas RM; Planas R
    J Clin Gastroenterol; 2011; 45(10):906-11. PubMed ID: 21814145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).
    Poynard T; Vergniol J; Ngo Y; Foucher J; Munteanu M; Merrouche W; Colombo M; Thibault V; Schiff E; Brass CA; Albrecht JK; Rudler M; Deckmyn O; Lebray P; Thabut D; Ratziu V; de Ledinghen V; ; ;
    J Hepatol; 2014 Apr; 60(4):706-14. PubMed ID: 24291240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
    Bosch J; Iwakiri Y
    Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver cirrhosis stages and the incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy.
    Shim JJ; Oh CH; Kim JW; Lee CK; Kim BH
    Scand J Gastroenterol; 2017 Sep; 52(9):1029-1036. PubMed ID: 28562104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of magnetic resonance elastography in compensated and decompensated liver disease.
    Asrani SK; Talwalkar JA; Kamath PS; Shah VH; Saracino G; Jennings L; Gross JB; Venkatesh S; Ehman RL
    J Hepatol; 2014 May; 60(5):934-9. PubMed ID: 24362072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.